Anti-Human DLL3 Recombinant Antibody_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human DLL3 Recombinant Antibody

Anti-Human DLL3 Recombinant Antibody

产品编号

YR1386

别名

科研级 Rovalpituzumab ( 洛伐妥珠单抗 ), Anti-DLL3 Recombinant Antibody, Research Grade Rovalpituzumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Rovalpituzumab ( 洛伐妥珠单抗 ), Anti-DLL3 Recombinant Antibody, Research Grade Rovalpituzumab
Catalog Number	YR1386
Molecular Name	Rovalpituzumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by Stemcentrx and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial.
CAS Number	1613313-01-1
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	DLL3[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0